Professor Yu Wang: Innovations and Advances in Transplantation Strategies for AML

Professor Yu Wang: Innovations and Advances in Transplantation Strategies for AML

Acute myeloid leukemia (AML) is a heterogeneous group of malignant clonal disorders originating from myeloid stem cells, characterized by significant biological diversity and generally poor prognosis. The global disease burden of AML continues to rise, with the age-standardized incidence increasing by 87.3% between 1990 and 2021, underscoring the urgent need for improved therapeutic strategies.
Professor Rong Fu: From Data to Mechanism—A Comprehensive Interpretation of Thrombosis in PNH and Emerging Strategies for Prevention and Management

Professor Rong Fu: From Data to Mechanism—A Comprehensive Interpretation of Thrombosis in PNH and Emerging Strategies for Prevention and Management

From March 27 to 28, 2026, the 9th Beijing Conference on Thrombosis and Hemostasis and the 7th Beijing Summit Forum on Hematologic Malignancies and Immunology was held in Beijing, bringing together leading experts from China and abroad to discuss advances in thrombosis, hemostasis, hematologic malignancies, and immunology.